[Pathomorphology of experimental Shigella keratoconjunctivitis in relation to the use of levomycetin and pentoxyl].
D000818:Animals; D002701:Chloramphenicol / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000494:pharmacology; D003228:Conjunctiva / Q000187:drug effects / Q000473:pathology; D003315:Cornea / Q000187:drug effects / Q000473:pathology; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006168:Guinea Pigs; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000382:microbiology*; D010118:Oxytetracycline / Q000494:pharmacology; D012760:Shigella / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014498:Uracil / Q000627:therapeutic use*
D014498:Uracil; D002701:Chloramphenicol; D013752:Tetracycline; D002751:Chlortetracycline; D010118:Oxytetracycline; D013307:Streptomycin
Patomorfologiia éksperimental'nogo shigelleznogo keratokon"iunktivita v zavisimosti ot primeneniia levomitsetina i pentoksila.